New Editors Use Reviewers That Have Not Been
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Bibliometric Analysis
787 Original Article Page 1 of 9 The 100 most cited articles on lung cancer screening: a bibliometric analysis Meng Li1,2, Qiang Cai2,3, Jing-Wen Ma1, Li Zhang1,2, Claudia I. Henschke2 1Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of Radiology, Mount Sinai Health System, New York, NY, USA; 3Department of Radiology, Shanxi Provincial People’s Hospital, Taiyuan, China Contributions: (I) Conception and design: M Li, CI Henschke; (II) Administrative support: CI Henschke; (III) Provision of study materials or patients: M Li, CI Henschke; (IV) Collection and assembly of data: M Li, L Zhang; (V) Data analysis and interpretation: M Li, Q Cai, JW Ma; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Claudia I. Henschke. Department of Radiology, Mount Sinai Health System, 1 Gustave Levy Place, New York, NY 10029, USA. Email: [email protected]. Background: The number of citations of an article reflects its impact on the scientific community. The aim of this study was to identify and characterize the 100 most cited articles on lung cancer screening. Methods: The 100 most cited articles on lung cancer screening published in all scientific journals were identified using the Web of Science database. Relevant data, including the number of citations, publication year, publishing journal and impact factor (IF), authorship and country of origin, article type and study design, screening modality, and main topic, were collected and analyzed. Results: The 100 most cited articles were all English and published between 1973 and 2017, with 81 published after 2000. -
Scientific Publications in Respiratory Journals from Chinese
Open Access Research BMJ Open: first published as 10.1136/bmjopen-2013-004201 on 28 February 2014. Downloaded from Scientific publications in respiratory journals from Chinese authors in various parts of North Asia: a 10-year survey of literature Bo Ye,1 Ting-Ting Du,1 Ting Xie,2 Jun-Tao Ji,1 Zhao-Hong Zheng,1 Zhuan Liao,1 Liang-Hao Hu,1 Zhao-Shen Li1 To cite: Ye B, Du T-T, Xie T, ABSTRACT et al Strengths and limitations of this study . Scientific publications in Objectives: Respiratory disease remains one of the respiratory journals from leading causes of morbidity and mortality in China. Chinese authors in various A few journals covered resources beyond respiratory However, little is known about the research status of parts of North Asia: a 10-year even selected from the respiratory system of Science — survey of literature. BMJ Open respirology in three major regions of China Mainland Citation Index Expanded (SCIE). Besides, some 2014;4:e004201. doi:10.1136/ (ML), Hong Kong (HK) and Taiwan (TW). A 10-year related journals not shown in SCIE were not col- bmjopen-2013-004201 survey of literature was conducted to compare the lected. Some respiratory medicine research articles three regions’ outputs in the research of respirology. were published in general journals, rather than in the ▸ Prepublication history for Design: A bibliometric study. specialized ones. Searching by the author’s address this paper is available online. Setting: China. (China, HK or TW) led to another problem that the To view these files please Participants and outcome measures: A literature articles which addressed other cities or provinces visit the journal online search in PubMed database, updated as of September were not included. -
British Thoracic Society Winter Meeting
February 2021 Volume 76 Supplement 1 76 S1 Volume 76 Supplement 1 Pages A1–A256 ThoraxAN INTERNATIONAL JOURNAL OF RESPIRATORY MEDICINE British Thoracic Society THORAX Winter Meeting Wednesday 17 to Friday 19 February 2021 Programme and Abstracts February 2021 February thorax.bmj.com PROGRAMME AND Thorax ABSTRACTS British Thoracic Society Winter Meeting Wednesday 17 to Friday 19 February 2021 Programme and Abstracts Approved by the Federation of the Royal Colleges of Physicians of the UK for 18 category I (external) credits (6 credits per day). Code: 133787 DAILY PROGRAMME WEDNESDAY 17 FEBRUARY 2021 All Symposia, Guest Lectures, Journal Clubs and Spoken Sessions will be shown online live at the times below, and will be available to view via the relevant ‘session type’ tab online. Poster presentations will be pre-recorded and available on demand each day and should be viewed prior to the Poster Discussion Q&A, which will be online live at the times below, all via the ‘Poster Sessions’ tab. Time Session Type Session Title 7.00am – 6.00pm Poster viewing on demand P1-P11 Lessons from COVID-19 throughout the day with live P12-P24 Lung cancer: treatment options and care pathways discussions at the programmed P38-P51 COPD: clinical science times P63-P75 Primary care and paediatric asthma P76-P88 Virtually systematic: current interventions and digital delivery in pulmonary rehabilitation 7.45am – 8.00am Symposium Daily preview 8.00am – 8.30am BTS Journal Club New insights to chronic cough 8.30am – 10.00am Symposium Neutrophilic asthma 8.30am – -
Paper Acceptance Time in Respiratory Research: Room for Improvement?
AGORA | RESEARCH LETTER Paper acceptance time in respiratory research: room for improvement? To the Editor: We recently submitted a paper to a top five respiratory journal in terms of average citations per article. The paper was swiftly sent for peer review. A month later, the review was in, and the paper was now “awaiting associate editor decision”. After another 6 weeks, and at the time of writing this letter, the paper is still with the handling editor. Like us, many authors have probably at this stage speculated when it would be reasonable to contact the editorial office and enquire about the status. A recent study carried out for Nature showed that the median time between submission and acceptance of a paper for 4375 different journals was approximately 100 days [1, 2]. The study was based on an analysis of all papers in PubMed for which these data were listed from 1965 to 2015 and included more than 6 million observations of acceptance and publication time. Somewhat surprisingly, the acceptance time has remained fairly constant for more than 30 years and may in fact underestimate the actual time, as not all journals choose to deposit these data. Moreover, some journals use the re-submission date rather than the date for initial submission as the “start date”, which may also bias the results. Based on this large dataset at hand, available on GitHub [2], it is possible to analyse acceptance time for most respiratory journals. If the analysis is restricted to those respiratory journals with more than three citations per paper over 2 years, of which there are 22 journals [3], 18820 papers are found with reported acceptance times. -
Annual General Meeting
ANNUAL GENERAL MEETING The ANNUAL GENERAL MEETING of the British Thoracic Society will be held on Wednesday 2nd December 2020 at 4:30PM virtually on Zoom. Please register in advance via Zoom: https://zoom.us/webinar/register/WN_FREtv- O6SYeHAq-FBBfXNw It would be fair to say that the BTS Strategic Plan highlighted in the 2019 AGM papers and Annual Report and aligned to the 4 UK Nations’ Health Plans, took a step back in 2020 due to the unprecedented challenges that the COVID-19 pandemic placed upon the global population and global healthcare. Specifically, this presented both the British public and our healthcare systems with huge challenges at all levels. Respiratory medicine, BTS and its members have stepped up to this task with impressive innovation, dedication, hard graft and positivity. BTS is, and has been, one of the premier sources of guidance on the management of COVID-19 with a dedicated website hosting BTS guidance, as well as information from government sources across the four nations and allied specialist societies. The webpages have been, and continue to be, viewed hundreds of thousands of times. We are all aware that we are not out of the fire by any stretch and the prospect of managing “endemic” acute COVID-19, COVID-19 follow up including “Post COVID-19 Syndrome” together with seasonal “Winter pressures” allied to our “usual” population of patients with respiratory disease is going to remain challenging. As with the general population, this has not been without a physical and emotional cost, with many of our members being infected and suffering stress, anxiety and potential burnout. -
Top 20 Journals Relevant to Overall Health Care Services Ranked by Impact Factor
The following lists of journals have been provided as a resource to assist the Quality Improvement community in identifying high impact journals, and journals influential in specific topic areas relevant to QI efforts within health care. Identified journals publish papers by both traditional and open access publication processes. Top 20 journals relevant to overall health care services ranked by impact factor: Journal Name Impact Factor CA-A CANCER JOURNAL FOR CLINICIANS (supports open access) 137.578 NEW ENGLAND JOURNAL OF MEDICINE 59.558 LANCET (supports open access) 44.002 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 37.684 NATURE MEDICINE 30.357 NATURE REVIEWS NEUROSCIENCE 29.298 LANCET ONCOLOGY (supports open access) 26.509 LANCET INFECTIOUS DISEASES (supports open access) 21.372 JOURNAL OF CLINICAL ONCOLOGY (supports open access) 20.982 BMJ-BRITISH MEDICAL JOURNAL (supports open access) 19.697 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (supports open access) 17.759 CIRCULATION (supports open access) 17.202 ANNALS OF INTERNAL MEDICINE 16.593 LANCENT DIABETES & ENDOCRINOLOGY (supports open access) 16.32 JAMA PSYCHIATRY 14.417 JAMA INTERNAL MEDICINE 14.00 PLOS MEDICINE (open access) 13.585 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 13.118 INTENSIVE CARE MEDICINE (supports open access) 10.125 Top 20 journals relevant to quality improvement in health care ranked by impact factor: Journal Name Impact Factor NEW ENGLAND JOURNAL OF MEDICINE 59.558 LANCET (supports open access) 44.002 JAMA-JOURNAL OF THE AMERICAN MEDICAL -
Bts Guideline for Oxygen Use in Adults in Healthcare And
June 2017 Volume 72 Supplement 1 72 S1 Volume 72 Supplement 1 Pages i1–i90 ThoraxAN INTERNATIONAL JOURNAL OF RESPIRATORY MEDICINE BTS GUIDELINE FOR OXYGEN USE THORAX IN ADULTS IN HEALTHCARE AND EMERGENCY SETTINGS British Thoracic Society Emergency Oxygen Guideline Development Group June 2017 thorax.bmj.com thoraxjnl_72_S1_Cover.indd 1 10/05/17 5:31 PM Endorsements Healthcare providers need to use clinical judgement, knowledge and expertise when deciding whether it is appropriate to apply recommendations for the management of patients. The recommendations cited here are a guide and may not be appropriate for use in all situations. The guidance provided does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer. thoraxjnl_72_S2_Title_Page.indd 2 11/05/17 6:51 PM BTS Emergency Oxygen Guideline Development Group B Ronan O’Driscoll, Luke Howard, John Earis, Vince Mak, Sabrina Bajwah, Richard Beasley, Katrina Curtis, Anthony Davison, Alistair Dorward, Chris Dyer, Angela Evans, Lucy Falconer, Clare Fitzpatrick, Simon Gibbs, Kim Hinshaw, Robin Howard, Binita Kane, Jeff Keep, Carol Kelly, Hasanin Khachi, Muhammed Asad Iqbal Khan, Roop Kishen, Leigh Mansfi eld, Bruce Martin, Fionna Moore, Duncan Powrie, Louise Restrick, Christine Roffe, Mervyn Singer, Jasmeet Soar, Iain Small, Lisa Ward, David Whitmore, Wisia Wedzicha, Meme Wijesinghe British Thoracic Society Emergency Oxygen Guideline Development Group On behalf -
Bibliometric Analysis of Ongoing Projects: Innovative Medicines Initiative Joint Undertaking (IMI)
Bibliometric analysis of ongoing projects: Innovative Medicines Initiative Joint Undertaking (IMI) IMI EXECUTIVE OFFICE Fourth report: April 2014 Prepared by Thomson Reuters on behalf of IMI JU Executive Office under a public procurement procedure Copyright IMI JU April 2014 Disclaimer/Legal Notice: This document and attachments have been prepared solely for the Innovative Medicines Initiative Joint Undertaking (IMI JU). All contents may not be re-used (in whatever form and by whatever medium) by any third party without prior permission of the IMI JU. 2 Copyright IMI JU April 2014 1 Executive Summary .......................................................................................................................... 5 2 Introduction ....................................................................................................................................... 9 2.1 Overview ................................................................................................................................. 9 2.2 Innovative Medicines Initiative Joint Undertaking (IMI) .......................................................... 9 2.3 Thomson Reuters ................................................................................................................... 9 2.4 Thomson Reuters Research Analytics ................................................................................. 10 2.5 Thomson Reuters Custom Analytics & Engineered Solutions ............................................. 10 2.6 Scope of this report .............................................................................................................. -
BTS Guideline for Bronchiectasis in Adults Has Been Endorsed By
January 2019 Volume 74 Supplement 1 AnThorax international journal of RESPIRATORY MEDICINE BRITISH THORACIC SOCIETY GUIDELINE FOR BRONCHIECTASIS IN ADULTS British Thoracic Society Bronchiectasis in Adults Guideline Development Group thorax.bmj.com BTS Bronchiectasis in Adults Guideline Development Group Professor Adam T Hill, Dr Anita L Sullivan, Professor James D Chalmers, Professor Anthony De Soyza, Professor J Stuart Elborn, Professor R Andres Floto, Ms Lizzie Grillo, Dr Kevin Gruffydd-Jones, Ms Alex Harvey, Dr Charles S Haworth, Mr Edwin Hiscocks, Dr John R Hurst, Dr Christopher Johnson, Dr W Peter Kelleher, Dr Pallavi Bedi, Miss Karen Payne, Mr Hesham Saleh, Dr Nicholas J Screaton, Dr Maeve Smith, Professor Michael Tunney, Dr Deborah Whitters, Professor Robert Wilson, Professor Michael R Loebinger On behalf of the British Thoracic Society The BTS Guideline for Bronchiectasis in Adults has been endorsed by: Association for Chartered Physiotherapists in Respiratory Care Association of Respiratory Nurse Specialists Primary Care Respiratory Society UK Royal College of Physicians London Healthcare providers need to use clinical judgement, knowledge and expertise when deciding whether it is appropriate to apply recommendations for the management of patients. The recommendations cited here are a guide and may not be appropriate for use in all situations. The guidance provided does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient -
ATHEROSCLEROSIS International Journal for Research and Investigation on Atherosclerosis and Related Diseases
ATHEROSCLEROSIS International Journal for Research and Investigation on Atherosclerosis and Related Diseases AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.6 ISSN: 0021-9150 DESCRIPTION . Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation. The Editors are interested in original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors. Complimentary online access is available to all members of the European Atherosclerosis Society. A reduced personal subscription rate is available to all members of the International Atherosclerosis Society. Please apply to the Publisher for more information. AUDIENCE . Researchers and clinicians working on atherosclerosis and related diseases, including: lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, and cardiovascular risk factors. IMPACT FACTOR . 2020: 5.162 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION